NRC

NRC Health

Healthcare · $469M market cap

Verdict

Share price

$20.35

close of Oct 3, 2026

Fair value

$12.36

Sticker Price

Payback Price

$4.95

buy price

Overpriced

NRC is Overpriced: at $20.35 it trades 65% above its fair value of $12.36. Its buy price (Payback Price) is $4.95, 76% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.

How we valued it

Free Cash Flow. Sales grew -3% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth8.8% a year✗
Equity per share growth-7.7% a year✗
Sales growth6.6% a year✗
Free cash flow growth7.1% a year✗
Return on invested capital24.5%✓

Follow NRC

Get notified when it reaches its buy price of $4.95. Free.

Create a free account

Insider activity

Since Jun 23, 2026: no open-market purchases and 5 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

About NRC Health

National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works